Presagen is an Australia-based company specializing in artificial-intelligence-driven medical imaging. The firm’s technology focuses on applying AI to medical images to enhance diagnostic capabilities and clinical decision-making. Presagen is still at an early stage of development, as indicated by its recent seed financing. The A$4.5 million seed round provides the company with fresh capital to advance product development and operational growth. Financial details beyond the seed raise have not been disclosed, and there are no publicly reported operating metrics such as revenue or user numbers in the available coverage. The presence of both private and governmental investors suggests market confidence in Presagen’s potential impact on healthcare imaging.

Total raised

$3M

Funding rounds

2

Latest round

Seed

Latest activity

Apr 2019